medigraphic.com
Instituto Nacional de Neurología y Neurocirugía

2019, Número 4

<< Anterior Siguiente >>

Arch Neurocien 2019; 24 (4)


Hemangiopericitoma / tumor fibroso solitario: presentación de caso y revisión de la literatura

Pérez-Martínez LE, Pérez-Garza LE, Hernández-Rodríguez VS, Alcocer-Gregory P

Idioma: Español
Referencias bibliográficas: 49
Paginas: 36-47
Archivo PDF: 654.08 Kb.


RESUMEN

El Hemangiopericitoma/Tumor Fibroso Solitario meníngeo es un tumor raro del sistema nervioso central que presenta una alta tasa de recidiva local y de metástasis extracraneal. Debido a su rareza, hay poco material estadístico para determinar el mejor tratamiento, pero se sabe que responden mejor a una resección total. Se revisa el tema debido al reciente cambio de nomenclatura y clasificación de este tipo de tumor y la presentación de un caso y su manejo. Posteriormente, se hace una revisión de la literatura para identificar la epidemiología, presentación, diagnóstico, valores predictivos y tratamiento actual a nivel global


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Stout AP, Murray MR. Hemangiopericytoma a vascular tumor featuring zimmermannjs pericytes. Ann Surg 1942; 116(1):26–33. doi:10.1097/00000658-194207000-00004.

  2. Rutkowski M J , Sughrue M E, Kane A J, Aranda D; et al. Predictors of mortality following treatment of intracranial hemangiopericytoma, J Neurosurg 2010; 113 (2):333–339. doi:10.3171/2010.3.JNS091882.

  3. Cushing H, Eisenhardt L. Meningiomas: their classification regional behavior, life history and surgical and results. Bull Med Libr Assoc 1938; 27(2): 185.

  4. Rutkowski M J, Jian B J, Bloch O, Chen C, et al. Intracranial hemangiopericytoma. Clinical experience and treatment considerations in a modern series of 40 adult patients. Cancer 2011;118 (6):1628–1636. doi:10.1002/cncr.26411.

  5. Schweizer L, Koelsche C, Sahm F, et al. Meningeal hemangiopericytoma and solitary fibrous tumors carry the NAB2-STAT6 fusion and can be diagnosed by nuclear expression of STAT6 protein. Acta Neuropathol 2013;125 (5):651–658. doi:10.1007/s00401-013-1117-6.

  6. Diamandis P, Aldape K. The world health organization 2016 classification of central nervous system tumors, Neurologic Clin 2018; 36 (3):439–447. doi:10.1016/j.ncl.2018.04.003.

  7. Guthrie BL, Ebersold MJ, Scheithauer BW, Shaw EG. Meningeal hemangiopericytoma: histopathological features, treatment, and long-term follow-up of 44 cases. Neurosur 1989; 25(4):514–522. doi:10.1227/00006123-198910000-00003.

  8. Gang L, Zhi-Ye C, Lin M, Xin L, Shi-Jun L, Yu-Lin W. Intracranial hemangiopericytoma: MR imaging findings and diagnostic usefulness of minimum ADC values. J Mag Res Ima 2013; 38(5):1146–1151. doi:10.1002/jmri.24075.

  9. Kakkar A , Kumar A, hJ a P, Goyal N, Mallick S, Sharma M. Meningeal hemangiopericy- tomas: A clinicopathological study with emphasis on MGMT (O6-methylguanine-DNA methyl-transferase) promoter methylation status. Neuropathology, Neuropathol 2014; 34(4):333–342. doi:10.1111/neup.12107

  10. Rutkowski MJ, Bloch O, Jian BJ, Chen C, Sughrue ME, Tihan T, Barani IJ, Berger MS, McDermott MW, Parsa AT. Management of recurrent intracranial hemangiopericytoma. J Clin Neurosci 2011; 18(11):1500-1504. doi:10.1016/j.jocn.2011.04.009.

  11. Olson C, Yen CP, Schlesinger D, Sheehan J. Radiosurgery for intracranial hemangiopericytomas: outcomes after initial and repeat Gamma Knife surgery. J Neurosurg 2010;112 (1):133–139. doi:10.3171/2009.3.JNS0923.

  12. Galanis E, Buckner JC, Scheithauer BW, Kimmel DW, Schomberg PJ, Piepgras DG.Management of recurrent meningeal hemangiopericytoma. Cancer 1998; 82(10):1915–1920.

  13. Komori T.The 2016 WHO Classification of tumours of the Central Nervous System: the major points of revision, Neurologia medico-chirurgica 2017;57 (7):301–311. https://doi.org/10.2176/nmc.ra.2017-0010

  14. Sung KS, Moon JH, Kim EH, Kang SG, Kim SH, Suh CO, Kim SH, Lee KS, Chang WS, Chang JH. Solitary fibrous tumor/ Hemangiopericytoma: treatment results based on 2016 WHO classification. J Neurosurg 2017;130(2): 337–673. doi:https://doi.org/10.3171/2017.9.JNS171057

  15. Jääskeläinen J, Servo A, Haltia M, Wahlström T, Valtonen S. Intracranial hemangiopericytoma: radiology, surgery, radiotherapy, and outcome in 21 patients. Surg Neurol 1985; 23(3):227– 236. doi:10.1016/0090-3019(85)90087-4.

  16. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P. The 2007 WHO Classification of Tumours of the Central Nervous System. Acta Neuropathol 2007; 114(2):97–109. doi:10.1007/ s00401-007-0243-4.

  17. Sonabend AM1, Zacharia BE, Goldstein H, Bruce SS, Hershman D, Neugut AI, Bruce JN. The role for adjuvant radiotherapy in the treatment of hemangiopericytoma: a surveillance, epidemiology, and End results analysis.J Neurosurg 2014;120(2):300–308. doi:10.3171/2013.10.JNS13113.

  18. Larijani L, Madjd Z, Samadikuchaksaraei A, Younespour S, Zham H, Rakhshan A, Mohammadi F, Rahbari A, Moradi A. Methylation of O6-Methyl Guanine Methyltransferase Gene Promoter in Meningiomas-Comparison between Tumor Grades I, II, and III., Asian Pac J Cancer Prev 2014;15(1):33–38. doi:10.7314/apjcp.2014.15.1.33.

  19. Ghose A, Guha G, Kundu R, Tew J, Chaudhary R. CNS Hemangiopericytoma: a systematic review of 523 patients. Am J Clin Oncol 2017; 40(3):223–227. doi:10.1097/coc.0000000000000146.

  20. Ecker RD, Marsh WR, Pollock BE, Kurtkaya-Yapicier O, McClelland R, Scheithauer BW, Buckner JC. Hemangiopericytoma in the central nervous system: treatment, pathological features, and long-term follow up in 38 patients. J Neurosurg 2003; 98(6):1182–1187. doi:10.3171/jns.2003.98.6.1182.

  21. Kim BS, Kim Y, Kong DS, Nam DH, Lee JI, Suh YL, Seol HJ. Clinical outcomes of intracranial solitary fibrous tumor and hemangiopericytoma: analysis according to the 2016 WHO classification of central nervous system tumors. J Neuros 2018;129(6):1384–1396. doi:10.3171/2017.7.JNS171226.

  22. Towner JE, Johnson MD, Li YM. Intraventricular Hemangiopericytoma: a case report and literature review. World Neuros 2016; 89(1):728.e5–728.e10. doi:10.1016/j.wneu.2016.01.056.

  23. Collignon FP, Cohen-Gadol AA, Piepgras DG. Hemangiopericytoma of the confluence of sinuses and the transverse sinuses. Case Report. J Neurosurg 2003; 99(6):1085–1088. doi:10.3171/jns.2003.99.6.1085.

  24. Abdollahi A, Abdollahpouri R, Tavangar SM. Meningeal hemangiopericytoma in a 33-year-old female; a case report. Iran J Pathol 2016; 11(3):281-285. doi:No disponible.

  25. Chen Q, Chen XZ, Wang JM, Li SW, Jiang T, Dai JP. Intracranial meningeal hemangiopericytomas in children and adolescents: CT and MR imaging findings. Am J Neuroradiol 2012; 33(1):195–199. doi:10.3174/ajnr.A2721.

  26. Seki S, Kamide T, Tamase A, Mori K, Yanagimoto K, Nomura M. Subarachnoid and intracerebral hemorrhage from intracranial hemangiopericytoma: an uncommon cause of intracranial hemorrhage. Neuroradiol J 2016; 29(3) :183-186. doi:10.1177/1971400916638352.

  27. Wei G, Kang X, Liu X, Tang X, Li Q, Han J, Yin H. Intracranial meningeal hemangiopericytoma: recurrences at the initial and distant intracranial sites and extraneural metastases to multiple organs. Mol Clin Oncol 2015;3(4):770- 774. doi:10.3892/mco.2015.537.

  28. Chiechi MV, Smirniotopoulos JG, Mena H. Intracranial hemangiopericytomas: MR and CT features. AJNR Am J Neuroradiol 1996;17(7):1365–1371. doi:No disponible.

  29. Righi V, Tugnoli V, Mucci A, Bacci A, Bonora S, Schenetti L. MRS study of meningeal hemangiopericytoma and edema: A comparison with meningothelial meningioma. Oncol Rep 2012; 28(4):1461-1467. doi:10.3892/or.2012.1919.

  30. Stetson N, Vadivelu S, et al. Angiographic evidence of a purely pial bihemispheric intracranial hemangiopericytoma. Case reports in Neurological Medicine 2016; (5245078):1–4. doi:10.1155/2016/5245078.

  31. Trabelsi S, Mama N, Chourabi M, Mastouri MH, Ladib M, Popov S, Burford A, Mokni M, Tlili K, Krifa H, Jones C, Yacoubi MT, Saad A, Brahim DH. Meningeal Hemangiopericytomas and Meningiomas: a comparative immunohistochemical and genetic study. Asian Pac J Cancer Prev 2015; 16(16):6871-6. doi: 10.7314/ apjcp.2015.16.16.6871

  32. S. Routray, N. Mohanty, S. Panda, S. R. Sahoo. Hemangiopericytoma/solitaryfibrous tumor of mandible: a rare entity. J Oral Maxillofac Pathol 2015;19(2):260-2. doi: 10.4103/0973-029X.164546.

  33. Kang M, Kim NR, Chung DH, Yie GT. Frozen cytology of meningeal malignant solitary fibrous tumor/ hemangiopericytoma. J Pathol Transl Med 2019;53(3):192-197. doi:10.4132/jptm.2019.03.20.

  34. Champeaux C, Khan AA, Wilson E, Thorne L, Dunn L.Meningeal haemangiopericytoma and solitary fibrous tumour: A retrospective bi centre study for outcome and prognostic factor assessment. J Neurooncol 2017;134(2):387- 395. doi: 10.1007/s11060-017-2538-1

  35. Nakada S, Minato H, Takegami T, Kurose N, Ikeda H, Kobayashi M, Sasagawa Y, Akai T, Kato T, Yamamoto N, Nojima T. NAB2–STAT6 fusion gene analysis in two cases of meningeal solitary fibrous tumor/hemangiopericytoma with late distant metastases. Brain Tumor Pathol 2015;32(4):268-74. doi: 10.1007/s10014-015-0220-x.

  36. Zhao P, Zhu T, Tang Q, Liu H, Zhu J, Zhang W. Immunohistochemical and genetic markers to distinguish hemangiopericytoma and meningioma. Int J Clin Exp Med 2015;15;8(3):3291-9. doi:No disponible.

  37. Plukker JT, Koops HS, Molenaar I, Vermey A, ten Kate LP, Oldhoff J. Malignant hemangiopericytoma in three kindred members of one family.. Cancer 1988;15;61(4):841-4. doi: 10.1002/1097-0142(19880215)61:4<841::aidcncr2820610433> 3.0.co;2-4

  38. Chmielecki J, Crago AM, Rosenberg M, O’Connor R, Walker SR, Ambrogio L, Auclair D, McKenna A, Heinrich MC, Frank DA, Meyerson M. Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors. Nat Genet 2013; 45(2):131-2. doi: 10.1038/ng.2522.

  39. Robinson DR, Wu YM, Kalyana-Sundaram S, Cao X, Lonigro RJ, Sung YS, et al. Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing. Nat Genet 2013;45(2):180-5. doi:10.1038/ng.2509

  40. Bhattacharyya S, Fang F, Tourtellotte W, Varga J. Egr-1: New conductor for the tissue repair orchestra directs harmony (regeneration) or cacophony (fibrosis). J Pathol 2013;229(2):286-97. doi: 10.1002/path.4131.

  41. SCombs SE1, Thilmann C, Debus J, Schulz-Ertner D. Precision radiotherapy for hemangiopericytomas of the central nervous system. Cancer. 2005 Dec 1;104(11):2457-65. doi:10.1002/cncr.21448.

  42. V. Vuorinen, P. Sallinen, H. Haapasalo, T. Visakorpi, M. Kallio, J. Jääskeläinen. Outcome of 31 intracranial haemangiopericytomas: Poor predictive value of cell proliferation indices. Acta Neurochir Wien 1996;138(12):1399- 1408. doi:10.1007/bf01411118.

  43. Peters KB, McLendon R, Morse MA, Vredenburgh JJ. Treatment of recurrent intracranial hemangiopericytoma with SRC-Related tyrosine kinase targeted therapy: a case report. Case Rep Oncol 2010; 8;3(1):93-97.

  44. S. H. Noh, J. J. Lim, K. G. Cho. Intracranial hemangiopericytomas : a retrospective study of 15 patients with a special review of recurrence. J Korean Neurosurg Soc 2015; 58(3):211-6. doi: 10.3340/jkns.2015.58.3.211.

  45. Dufour H, Métellus P, Fuentes S, Murracciole X, Régis J, et al.Meningeal hemangiopericytoma: a retrospective study of 21 patients with special review of postoperative external radiotherapy. Neurosurg 2001; 48(4):756–762. doi:10.1097/00006123-200104000-00011.

  46. Lee JK, Kim SH, Joo SP, Kim TS, Jung S, Kim JH, Lee JH.Spinal metastasis from cranial meningeal hemangiopericytomas. Acta Neurochir 2006; 148(7):787–790. doi:10.1007/s00701-006-0766-9.

  47. Joo MS, Rho YJ, Song SW, Koh YC, Roh HG2 Lim SD3. Metastatic Intracranial Heman- giopericytoma to the Spinal Column: a case report. Brain Tumor Res Treat 2016; 4(2):128–132. doi:10.14791/btrt.2016.4.2.128.

  48. Fountas KN, Kapsalaki E, Kassam M, Feltes CH, Dimopoulos VG, Robinson JS, Smith JR. Management of intracranial meningeal hemangiopericytomas: outcome and experience. Neurosurg Rev 2006; 29(2):145–153. doi:10.1007/ s10143-005-0001-9.

  49. Ciliberti MP, D’Agostino R, Gabrieli L, Nikolaou A, Sardaro A. The radiation therapy options of intracranial hemangiopericytoma: An overview and update on a rare vascular mesenchymal tumor. Oncol Rev 2018; 12(2):354. doi:10.4081/oncol.2018.354.




2020     |     www.medigraphic.com